Cargando…

Expression and characterization of a soluble VEGF receptor 2 protein

OBJECTIVE: To clone and express a truncated, soluble vascular endothelial growth factor receptor 2 (sVEGFR2) possessing the combined-functional domains 1–3 and 5 in eukaryotic cells and to test the inhibitory effects of full length VEGFR2 in vivo. RESULTS: pCMV6-trunctated-rVegfr2 (6100 bp) was succ...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wei, Zhang, Xinyuan, Song, Ching, Bao, Shisan, Lai, Donna, Mou, Jianqiu, Jiang, Tao, Wang, Ningli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977943/
https://www.ncbi.nlm.nih.gov/pubmed/24618407
http://dx.doi.org/10.1186/2045-3701-4-14
_version_ 1782310482208620544
author Liu, Wei
Zhang, Xinyuan
Song, Ching
Bao, Shisan
Lai, Donna
Mou, Jianqiu
Jiang, Tao
Wang, Ningli
author_facet Liu, Wei
Zhang, Xinyuan
Song, Ching
Bao, Shisan
Lai, Donna
Mou, Jianqiu
Jiang, Tao
Wang, Ningli
author_sort Liu, Wei
collection PubMed
description OBJECTIVE: To clone and express a truncated, soluble vascular endothelial growth factor receptor 2 (sVEGFR2) possessing the combined-functional domains 1–3 and 5 in eukaryotic cells and to test the inhibitory effects of full length VEGFR2 in vivo. RESULTS: pCMV6-trunctated-rVegfr2 (6100 bp) was successfully cloned. The transfection experiments showed that either pCMV6-truncated-rat-Vegfr2 (pCMV6-truncated-rVegfr2) or pCMV6-rVegfr2 inhibited the expression of intracellular green fluorescent protein, which is usually used as an exogenous transfected reporter gene to determine the transfected efficiency. An analysis of the transfected cells revealed that the amount of full-length VEGFR2 protein in the pCMV6-truncated-rVegfr2 transfected cells was 20% lower than that in the negative control (non-transfected HEK 293 cells). The differences in test results between the transfected and negative control groups were greatest from 24–30 h after transfection; this period was therefore chosen as optimal for collecting culture supernatants. This analysis was highly sensitive for detecting the amount of sVEGFR2 protein expressed and secreted by the cells, and the sVEGFR2 protein content was found to increase by approximately 26% in the transfected cells compared to that in the negative control cells (68.2% ± 1.7% vs. 41.9% ± 2.9%, P = 0.000) and by 18% compared to the negative control cells (68.2% ± 1.7% vs. 50.0% ± 0.5%, P = 0.003). Propidium iodide and Hoechst staining indicated no significant change in the number of HEK293 cells undergoing apoptosis 6 days after pCMV6-trucated-Vegfr2 transfection, compared to the negative control. Soluble VEGFR2 produced by pCMV6-truncated-rVegfr2 inhibited full-length VEGFR2 protein expression in the cell membrane. CONCLUSIONS: This study employed a eukaryotic system to express sVEGFR2. The use of transient transfection technology greatly improved transfect efficiency. Recombinant sVEGFR2 inhibited the effect of endogenous full-length VEGFR2 but was not cytotoxic.
format Online
Article
Text
id pubmed-3977943
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39779432014-04-21 Expression and characterization of a soluble VEGF receptor 2 protein Liu, Wei Zhang, Xinyuan Song, Ching Bao, Shisan Lai, Donna Mou, Jianqiu Jiang, Tao Wang, Ningli Cell Biosci Research OBJECTIVE: To clone and express a truncated, soluble vascular endothelial growth factor receptor 2 (sVEGFR2) possessing the combined-functional domains 1–3 and 5 in eukaryotic cells and to test the inhibitory effects of full length VEGFR2 in vivo. RESULTS: pCMV6-trunctated-rVegfr2 (6100 bp) was successfully cloned. The transfection experiments showed that either pCMV6-truncated-rat-Vegfr2 (pCMV6-truncated-rVegfr2) or pCMV6-rVegfr2 inhibited the expression of intracellular green fluorescent protein, which is usually used as an exogenous transfected reporter gene to determine the transfected efficiency. An analysis of the transfected cells revealed that the amount of full-length VEGFR2 protein in the pCMV6-truncated-rVegfr2 transfected cells was 20% lower than that in the negative control (non-transfected HEK 293 cells). The differences in test results between the transfected and negative control groups were greatest from 24–30 h after transfection; this period was therefore chosen as optimal for collecting culture supernatants. This analysis was highly sensitive for detecting the amount of sVEGFR2 protein expressed and secreted by the cells, and the sVEGFR2 protein content was found to increase by approximately 26% in the transfected cells compared to that in the negative control cells (68.2% ± 1.7% vs. 41.9% ± 2.9%, P = 0.000) and by 18% compared to the negative control cells (68.2% ± 1.7% vs. 50.0% ± 0.5%, P = 0.003). Propidium iodide and Hoechst staining indicated no significant change in the number of HEK293 cells undergoing apoptosis 6 days after pCMV6-trucated-Vegfr2 transfection, compared to the negative control. Soluble VEGFR2 produced by pCMV6-truncated-rVegfr2 inhibited full-length VEGFR2 protein expression in the cell membrane. CONCLUSIONS: This study employed a eukaryotic system to express sVEGFR2. The use of transient transfection technology greatly improved transfect efficiency. Recombinant sVEGFR2 inhibited the effect of endogenous full-length VEGFR2 but was not cytotoxic. BioMed Central 2014-03-11 /pmc/articles/PMC3977943/ /pubmed/24618407 http://dx.doi.org/10.1186/2045-3701-4-14 Text en Copyright © 2014 Liu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liu, Wei
Zhang, Xinyuan
Song, Ching
Bao, Shisan
Lai, Donna
Mou, Jianqiu
Jiang, Tao
Wang, Ningli
Expression and characterization of a soluble VEGF receptor 2 protein
title Expression and characterization of a soluble VEGF receptor 2 protein
title_full Expression and characterization of a soluble VEGF receptor 2 protein
title_fullStr Expression and characterization of a soluble VEGF receptor 2 protein
title_full_unstemmed Expression and characterization of a soluble VEGF receptor 2 protein
title_short Expression and characterization of a soluble VEGF receptor 2 protein
title_sort expression and characterization of a soluble vegf receptor 2 protein
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977943/
https://www.ncbi.nlm.nih.gov/pubmed/24618407
http://dx.doi.org/10.1186/2045-3701-4-14
work_keys_str_mv AT liuwei expressionandcharacterizationofasolublevegfreceptor2protein
AT zhangxinyuan expressionandcharacterizationofasolublevegfreceptor2protein
AT songching expressionandcharacterizationofasolublevegfreceptor2protein
AT baoshisan expressionandcharacterizationofasolublevegfreceptor2protein
AT laidonna expressionandcharacterizationofasolublevegfreceptor2protein
AT moujianqiu expressionandcharacterizationofasolublevegfreceptor2protein
AT jiangtao expressionandcharacterizationofasolublevegfreceptor2protein
AT wangningli expressionandcharacterizationofasolublevegfreceptor2protein